Based on our in vitro data, the next step would be to examine whether BCL-XL overexpression could prevent diabetes in animal models (e.g., NOD and db/db mice, respectively models for type 1 and type 2 diabetes). Here, BCL2L1 is linked to type 2 diabetes mellitus.